US Stock MarketDetailed Quotes

NVNO enVVeno Medical

Watchlist
  • 5.510
  • +0.120+2.23%
Close Aug 23 16:00 ET
73.45MMarket Cap-3992P/E (TTM)

enVVeno Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-19.96%5.45M
-19.04%5.5M
1.23%25.24M
-2.82%6.28M
-13.04%5.35M
-2.46%6.81M
27.40%6.8M
47.59%24.93M
-28.17%6.46M
127.23%6.15M
Selling and administrative expenses
1.12%2.63M
-23.45%2.45M
-22.39%11.66M
-9.99%3.3M
-30.28%2.55M
-33.55%2.6M
-15.36%3.2M
34.51%15.02M
-49.20%3.66M
146.90%3.66M
Research and development costs
-32.96%2.83M
-15.10%3.05M
37.01%13.58M
6.58%2.98M
12.28%2.8M
37.13%4.21M
131.64%3.6M
73.08%9.91M
56.96%2.8M
103.43%2.49M
Operating profit
19.96%-5.45M
19.04%-5.5M
-1.23%-25.24M
2.82%-6.28M
13.04%-5.35M
2.46%-6.81M
-27.40%-6.8M
-47.59%-24.93M
28.17%-6.46M
-127.23%-6.15M
Net non-operating interest income expense
87.18%73K
31.11%59K
11.80%180K
18.18%52K
-41.33%44K
5.41%39K
800.00%45K
747.37%161K
780.00%44K
1,400.00%75K
Non-operating interest income
87.18%73K
31.11%59K
11.80%180K
18.18%52K
-41.33%44K
5.41%39K
800.00%45K
747.37%161K
780.00%44K
1,400.00%75K
Other net income (expense)
41.20%425K
25.56%452K
1,411.76%1.54M
144.49%577K
1,547.62%304K
366.37%301K
360K
-70.52%102K
236K
-106.71%-21K
Gain on sale of security
41.20%425K
25.56%452K
1,411.76%1.54M
144.49%577K
1,547.62%304K
366.37%301K
--360K
--102K
--236K
---21K
Income before tax
23.45%-4.96M
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
Income tax
Net income
23.45%-4.96M
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
Net income continuous Operations
23.45%-4.96M
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
Minority interest income
Net income attributable to the parent company
23.45%-4.96M
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
23.45%-4.96M
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
Basic earnings per share
46.55%-0.31
45.61%-0.31
13.18%-1.91
41.82%-0.32
16.67%-0.45
7.94%-0.58
-21.28%-0.57
-15.79%-2.2
41.49%-0.55
-107.69%-0.54
Diluted earnings per share
46.55%-0.31
45.61%-0.31
13.18%-1.91
41.82%-0.32
16.67%-0.45
7.94%-0.58
-21.28%-0.57
-15.79%-2.2
41.49%-0.55
-107.69%-0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -19.96%5.45M-19.04%5.5M1.23%25.24M-2.82%6.28M-13.04%5.35M-2.46%6.81M27.40%6.8M47.59%24.93M-28.17%6.46M127.23%6.15M
Selling and administrative expenses 1.12%2.63M-23.45%2.45M-22.39%11.66M-9.99%3.3M-30.28%2.55M-33.55%2.6M-15.36%3.2M34.51%15.02M-49.20%3.66M146.90%3.66M
Research and development costs -32.96%2.83M-15.10%3.05M37.01%13.58M6.58%2.98M12.28%2.8M37.13%4.21M131.64%3.6M73.08%9.91M56.96%2.8M103.43%2.49M
Operating profit 19.96%-5.45M19.04%-5.5M-1.23%-25.24M2.82%-6.28M13.04%-5.35M2.46%-6.81M-27.40%-6.8M-47.59%-24.93M28.17%-6.46M-127.23%-6.15M
Net non-operating interest income expense 87.18%73K31.11%59K11.80%180K18.18%52K-41.33%44K5.41%39K800.00%45K747.37%161K780.00%44K1,400.00%75K
Non-operating interest income 87.18%73K31.11%59K11.80%180K18.18%52K-41.33%44K5.41%39K800.00%45K747.37%161K780.00%44K1,400.00%75K
Other net income (expense) 41.20%425K25.56%452K1,411.76%1.54M144.49%577K1,547.62%304K366.37%301K360K-70.52%102K236K-106.71%-21K
Gain on sale of security 41.20%425K25.56%452K1,411.76%1.54M144.49%577K1,547.62%304K366.37%301K--360K--102K--236K---21K
Income before tax 23.45%-4.96M21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M
Income tax
Net income 23.45%-4.96M21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M
Net income continuous Operations 23.45%-4.96M21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M
Minority interest income
Net income attributable to the parent company 23.45%-4.96M21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 23.45%-4.96M21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M
Basic earnings per share 46.55%-0.3145.61%-0.3113.18%-1.9141.82%-0.3216.67%-0.457.94%-0.58-21.28%-0.57-15.79%-2.241.49%-0.55-107.69%-0.54
Diluted earnings per share 46.55%-0.3145.61%-0.3113.18%-1.9141.82%-0.3216.67%-0.457.94%-0.58-21.28%-0.57-15.79%-2.241.49%-0.55-107.69%-0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg